Track topics on Twitter Track topics that are important to you
Catherine Stehman-Breen is moving to Sarepta Therapeutics (NASDAQ: SRPT) to become the Cambridge, MA, company’s chief medical officer. Stehman-Breen previously served as vice president of clinical development and regulatory affairs for Regeneron Pharmaceuticals (NASDAQ: REGN), a Tarrytown, NY, biotech. Before joining Regeneron in 2015, Stehman-Breen held several posts at Amgen (NASDAQ: AMGN).
Original Article: Sarepta Appoints Catherine Stehman-Breen Chief Medical OfficerNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...